Chongqing Zhifei Bio Products - Asset Resilience Ratio

Latest as of September 2023: -0.08%

Chongqing Zhifei Bio Products (300122) has an Asset Resilience Ratio of -0.08% as of September 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read 300122 current and long-term liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

CN¥-41.38 Million

≈ $-6.05 Million USD Cash + Short-term Investments

Total Assets

CN¥49.27 Billion

≈ $7.21 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2014–2022)

This chart shows how Chongqing Zhifei Bio Products's Asset Resilience Ratio has changed over time. See net assets of Chongqing Zhifei Bio Products for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Chongqing Zhifei Bio Products's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 300122 company net worth.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥-41.38 Million	-0.08%
Total Liquid Assets	CN¥-41.38 Million	-0.08%

Asset Resilience Insights

Limited Liquidity: Chongqing Zhifei Bio Products maintains only -0.08% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Chongqing Zhifei Bio Products Industry Peers by Asset Resilience Ratio

Compare Chongqing Zhifei Bio Products's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Merus BV NASDAQ:MRUS	Biotechnology	29.69%
Shanghai Allist Pharmaceuticals Co. Ltd. A SHG:688578	Biotechnology	30.29%
Beijing Tiantan Biological Products Corp Ltd SHG:600161	Biotechnology	8.08%
Beijing Hotgen Biotech Co Ltd SHG:688068	Biotechnology	20.87%
Savara Inc NASDAQ:SVRA	Biotechnology	76.71%
Wuhan Hvsen Biotechnology Co Ltd SHE:300871	Biotechnology	9.59%
Wecome Pharmaceutical Co Ltd SHE:300878	Biotechnology	0.67%
Shanghai Shen Lian Biomedical Corp SHG:688098	Biotechnology	3.87%

Annual Asset Resilience Ratio for Chongqing Zhifei Bio Products (2014–2022)

The table below shows the annual Asset Resilience Ratio data for Chongqing Zhifei Bio Products.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2022-12-31	-0.03%	CN¥-10.15 Million ≈ $-1.49 Million	CN¥38.00 Billion ≈ $5.56 Billion	+0.14pp
2021-12-31	-0.17%	CN¥-51.45 Million ≈ $-7.53 Million	CN¥30.05 Billion ≈ $4.40 Billion	+0.15pp
2020-12-31	-0.32%	CN¥-49.19 Million ≈ $-7.20 Million	CN¥15.22 Billion ≈ $2.23 Billion	-0.76pp
2019-12-31	0.44%	CN¥48.09 Million ≈ $7.04 Million	CN¥10.94 Billion ≈ $1.60 Billion	+0.92pp
2018-12-31	-0.49%	CN¥-33.04 Million ≈ $-4.84 Million	CN¥6.81 Billion ≈ $996.54 Million	-0.38pp
2017-12-31	-0.11%	CN¥-4.41 Million ≈ $-644.69K	CN¥4.11 Billion ≈ $600.82 Million	+0.14pp
2016-12-31	-0.25%	CN¥-6.76 Million ≈ $-989.50K	CN¥2.71 Billion ≈ $396.48 Million	-0.28pp
2015-12-31	0.03%	CN¥782.09K ≈ $114.44K	CN¥2.68 Billion ≈ $392.41 Million	+0.39pp
2014-12-31	-0.36%	CN¥-9.72 Million ≈ $-1.42 Million	CN¥2.71 Billion ≈ $397.21 Million	--

pp = percentage points

About Chongqing Zhifei Bio Products

SHE:300122 China Biotechnology

Market Cap

$5.42 Billion

CN¥37.03 Billion CNY

Market Cap Rank

#3425 Global

#529 in China

Share Price

CN¥15.47

Change (1 day)

+0.59%

52-Week Range

CN¥14.78 - CN¥25.06

All Time High

CN¥11976.62